A major advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in many types of cancer, resulting uncontrolled https://monobookmarks.com/story21834410/vhh-fragments-reactivate-the-p53-protein-new-potential-hope-for-cancer-treatment